Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Gastroenterology
|
October 13, 2012
Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis
Alfred S L Cheng, May S Li, Wei Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
Joanna H Tong, Sai F Yeung, Anthony W H Chan, et al.
Cancer Research
|
September 19, 2015
Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
Yuan Tian, Vincent W S Wong, Grace L H Wong, et al.
Briefings in Bioinformatics
|
March 30, 2021
Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance
Dan Huang, Xiansong Wang, Yingzhi Liu, et al.
The New England Journal of Medicine
|
January 22, 2005
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding
Francis K L Chan, Jessica Y L Ching, Lawrence C T Hung, et al.
Gut
|
June 22, 2014
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
Jun Yu, William K K Wu, Xiangchun Li, et al.
Cancer Research
|
October 27, 2012
Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer
Shun X Ren, Alfred S L Cheng, Ka F To, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo, Hyun C Chung, Stephen L Chan, et al.
The American Journal of Pathology
|
February 27, 2007
Hypermethylation of RASSF1A in human and rhesus placentas
Rossa W K Chiu, Stephen S C Chim, Ivy H N Wong, et al.
Cancer Research
|
December 16, 2014
Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis
Jing Shen, Zhangang Xiao, William K K Wu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Gastroenterology
|
October 13, 2012
Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis
Alfred S L Cheng, May S Li, Wei Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
Joanna H Tong, Sai F Yeung, Anthony W H Chan, et al.
Cancer Research
|
September 19, 2015
Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
Yuan Tian, Vincent W S Wong, Grace L H Wong, et al.
Briefings in Bioinformatics
|
March 30, 2021
Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance
Dan Huang, Xiansong Wang, Yingzhi Liu, et al.
The New England Journal of Medicine
|
January 22, 2005
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding
Francis K L Chan, Jessica Y L Ching, Lawrence C T Hung, et al.
Gut
|
June 22, 2014
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
Jun Yu, William K K Wu, Xiangchun Li, et al.
Cancer Research
|
October 27, 2012
Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer
Shun X Ren, Alfred S L Cheng, Ka F To, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Winnie Yeo, Hyun C Chung, Stephen L Chan, et al.
The American Journal of Pathology
|
February 27, 2007
Hypermethylation of RASSF1A in human and rhesus placentas
Rossa W K Chiu, Stephen S C Chim, Ivy H N Wong, et al.
Cancer Research
|
December 16, 2014
Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis
Jing Shen, Zhangang Xiao, William K K Wu, et al.
Page
of 5